Actionable news
All posts from Actionable news
Actionable news in FPRX: Five Prime Therapeutics, Inc.,

Departure of Directors or Certain

On November16, 2015, the Compensation Committee of the Board of Directors of Five Prime Therapeutics, Inc. (FivePrime) approved the grant of a restricted stock award (the Award) to Lewis T. Williams, M.D., Ph.D., FivePrimes President and Chief Executive Officer, under FivePrimes 2013 Omnibus Incentive Plan (the Plan). The Award consists of 50,000 shares of restricted stock, half of which will vest on September1, 2016 and the remaining half of which will vest on March1, 2017, provided that Dr.Williams...